192 related articles for article (PubMed ID: 31855720)
1. Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis.
Uzawa A; Ozawa Y; Yasuda M; Oda F; Kojima Y; Kawaguchi N; Kanai T; Himuro K; Kuwabara S
J Neuroimmunol; 2020 Feb; 339():577125. PubMed ID: 31855720
[TBL] [Abstract][Full Text] [Related]
2. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
[TBL] [Abstract][Full Text] [Related]
3. High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
Uzawa A; Akamine H; Kojima Y; Ozawa Y; Yasuda M; Onishi Y; Sawai S; Kawasaki K; Asano H; Ohyama S; Matsushita K; Mori M; Kuwabara S
J Neuroimmunol; 2021 Sep; 358():577634. PubMed ID: 34174586
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravis.
Shi QG; Wang ZH; Ma XW; Zhang DQ; Yang CS; Shi FD; Yang L
Neurosci Bull; 2012 Oct; 28(5):469-74. PubMed ID: 22961471
[TBL] [Abstract][Full Text] [Related]
5. False-positive acetylcholine receptor antibody results in patients without myasthenia gravis.
Maddison P; Sadalage G; Ambrose PA; Jacob S; Vincent A
J Neuroimmunol; 2019 Jul; 332():69-72. PubMed ID: 30959340
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
7. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
[TBL] [Abstract][Full Text] [Related]
8. Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis.
Ching KH; Burbelo PD; Kimball RM; Clawson LL; Corse AM; Iadarola MJ
Neuromuscul Disord; 2011 Mar; 21(3):204-13. PubMed ID: 21195619
[TBL] [Abstract][Full Text] [Related]
9. Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.
Schroeter CB; Nelke C; Stascheit F; Huntemann N; Preusse C; Dobelmann V; Theissen L; Pawlitzki M; Räuber S; Willison A; Vogelsang A; Marina AD; Hartung HP; Melzer N; Konen FF; Skripuletz T; Hentschel A; König S; Schweizer M; Stühler K; Poschmann G; Roos A; Stenzel W; Meisel A; Meuth SG; Ruck T
Acta Neuropathol; 2024 Jun; 147(1):102. PubMed ID: 38888758
[TBL] [Abstract][Full Text] [Related]
10. A Stable Cell Line Expressing Clustered AChR: A Novel Cell-Based Assay for Anti-AChR Antibody Detection in Myasthenia Gravis.
Cai Y; Han L; Zhu D; Peng J; Li J; Ding J; Luo J; Hong R; Wang K; Wan W; Xie C; Zhou X; Zhang Y; Hao Y; Guan Y
Front Immunol; 2021; 12():666046. PubMed ID: 34305897
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis.
Masuda T; Motomura M; Utsugisawa K; Nagane Y; Nakata R; Tokuda M; Fukuda T; Yoshimura T; Tsujihata M; Kawakami A
J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):935-40. PubMed ID: 22764264
[TBL] [Abstract][Full Text] [Related]
12. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
Somnier FE
Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
[TBL] [Abstract][Full Text] [Related]
13. Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma.
Ishikawa H; Taniguchi A; Ii Y; Higuchi O; Matsuo H; Nakane S; Asahi M; Niwa A; Tomimoto H
Neuromuscul Disord; 2017 Oct; 27(10):914-917. PubMed ID: 28694075
[TBL] [Abstract][Full Text] [Related]
14. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
Jacob S; Viegas S; Leite MI; Webster R; Cossins J; Kennett R; Hilton-Jones D; Morgan BP; Vincent A
Arch Neurol; 2012 Aug; 69(8):994-1001. PubMed ID: 22689047
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
[TBL] [Abstract][Full Text] [Related]
16. The role of antibodies in myasthenia gravis.
De Baets M; Stassen MH
J Neurol Sci; 2002 Oct; 202(1-2):5-11. PubMed ID: 12220686
[TBL] [Abstract][Full Text] [Related]
17. Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?
Sanders DB; Burns TM; Cutter GR; Massey JM; Juel VC; Hobson-Webb L;
Muscle Nerve; 2014 Apr; 49(4):483-6. PubMed ID: 23835683
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
[TBL] [Abstract][Full Text] [Related]
19. [Autoantibodies in myasthenia gravis].
Motomura M; Narita Masuda T
Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
[TBL] [Abstract][Full Text] [Related]
20. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
